1. AckermanBH, KasbekarN. Disturbances of taste and smell induced by drugs. Pharmacotherapy1997;17:482.

2. HenkinRI. Drug‐induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf1994;11:318. CrossRef

3. MoselDD, BauerRL, LynchDP, et al.Oral complications in the treatment of cancer patients. Oral Dis2011;17:550. CrossRef

4. BerzinTM, GreenbergerNJ, LevyBD, et al.Clinical problem‐solving. Worth a second look. N Engl J Med2012;366:463. CrossRef

5. ZakrzewskaJM, ForssellH, GlennyAM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev2005;(1):CD002779.

6. BuchananJ, ZakrzewskaJ. Burning mouth syndrome. Clin Evid2005;14:1685.

7. PintoA, SollecitoTP, DeRossiSS. Burning mouth syndrome. A retrospective analysis of clinical characteristics and treatment outcomes. N Y State Dent J2003;69:18.

8. PintoA, StooplerET, DeRossiSS, et al.Burning mouth syndrome: a guide for the general practitioner. Gen Dent2003;51:458, quiz 62.

9. MaysJW, SarmadiM, MoutsopoulosNM. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract2012;12(3 Suppl):265. CrossRef

10. RogersRS3rd.Recurrent aphthous stomatitis in the diagnosis of Behcet's disease. Yonsei Med J1997;38:370. CrossRef

11. LallaRV, ChoquetteLE, FeinnRS, et al.Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double‐masked, placebo‐controlled trial. J Am Dent Assoc2012;143:370. CrossRef

12. AltenburgA, Abdel‐NaserMB, SeeberH, et al.Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol2007;21:1019. CrossRef

13. AlidaeeMR, TaheriA, MansooriP, et al.Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial. Br J Dermatol2005;153:521. CrossRef

14. LyndeCB, BruceAJ, RogersRS3rd.Successful treatment of complex aphthosis with colchicine and dapsone. Arch Dermatol2009;145:273. CrossRef

15. PastoreL, CarroccioA, CompilatoD, et al.Oral manifestations of celiac disease. J Clin Gastroenterol2008;42:224. CrossRef

16. BohmerT, MoweM. The association between atrophic glossitis and protein‐calorie malnutrition in old age. Age Ageing2000;29:47. CrossRef

17. LenaneP, PowellFC. Oral pigmentation. J Eur Acad Dermatol Venereol2000;14:448. CrossRef

18. AbbasiNR, ShawHM, RigelDS, et al.Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA2004;292:2771. CrossRef

19. PaceF, PallottaS, ToniniM, et al.Systematic review: gastro‐oesophageal reflux disease and dental lesions. Aliment Pharmacol Ther2008;27:1179. CrossRef

20. SchroederPL, FillerSJ, RamirezB, et al.Dental erosion and acid reflux disease. Ann Intern Med1995;122:809. CrossRef

21. BouchouchaM, CallaisF, RenardP, et al.Relationship between acid neutralization capacity of saliva and gastro‐oesophageal reflux. Arch Physiol Biochem1997;105:19. CrossRef

22. MarsicanoJA, de Moura‐GrecPG, BonatoRC, et al.Gastroesophageal reflux, dental erosion, and halitosis in epidemiological surveys: a systematic review. Eur J Gastroenterol Hepatol2013;25:135. CrossRef

23. HomC, VaeziMF. Extra‐esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drugs2013;73:1281. CrossRef

24. JoseFA, GarnettEA, VittinghoffE, et al.Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis2009;15:63. CrossRef

25. LisciandranoD, RanziT, CarrassiA, et al.Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol1996;91:7.

26. BasuMK, AsquithP, ThompsonRA, et al.Oral manifestations of Crohn's disease. Gut1975;16:249. CrossRef

27. DupuyA, CosnesJ, RevuzJ, et al.Oral Crohn disease: clinical characteristics and long‐term follow‐up of 9 cases. Arch Dermatol1999;135:439. CrossRef

28. PlauthM, JenssH, MeyleJ. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol1991;13:29. CrossRef

29. HartyS, FlemingP, RowlandM, et al.A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol2005;3:886. CrossRef

30. PittockS, DrummB, FlemingP, et al.The oral cavity in Crohn's disease. J Pediatr2001;138:767. CrossRef

31. GreensteinAJ, JanowitzHD, SacharDB. The extra‐intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore)1976;55:401. CrossRef

32. HegartyA, HodgsonT, PorterS. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2003;95:576. CrossRef

33. NicoMM, HusseinTP, AokiV, et al.Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus. J Oral Pathol Med2012;41:584. CrossRef

34. ShahS, CotliarJ. Images in clinical medicine. Pyostomatitis vegetans. N Engl J Med2013;368:1918. CrossRef

35. AineL, MakiM, CollinP, et al.Dental enamel defects in celiac disease. J Oral Pathol Med1990;19:241. CrossRef

36. FerrazEG, Campos EdeJ, SarmentoVA, et al.The oral manifestations of celiac disease: information for the pediatric dentist. Pediatr Dent2012;34:485.

37. FraserD, NikiforukG. The etiology of enamel hypoplasia in children–a unifying concept. J Int Assoc Dent Child1982;13:1.

38. JacobsohnDA, KurlandBF, PidalaJ, et al.Correlation between NIH composite skin score, patient‐reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood2012;120:2545, quiz 774. CrossRef

39. FilipovichAH, WeisdorfD, PavleticS, et al.National Institutes of Health consensus development project on criteria for clinical trials in chronic graft‐versus‐host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant2005;11:945. CrossRef

40. SchubertMM, SullivanKM. Recognition, incidence, and management of oral graft‐versus‐host disease. NCI Monogr1990;9:135.

41. McDonaldGB, SullivanKM, PlumleyTF. Radiographic features of esophageal involvement in chronic graft‐vs.‐host disease. AJR Am J Roentgenol1984;142:501. CrossRef

42. PierelliL, PerseghinP, MarchettiM, et al.Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion2013;53:2340.

43. EladS, OrR, GarfunkelAA, et al.Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2003;95:308. CrossRef

44. EckardtA, StarkeO, StadlerM, et al.Severe oral chronic graft‐versus‐host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncol2004;40:811. CrossRef

45. CourielD, CarpenterPA, CutlerC, et al.Ancillary therapy and supportive care of chronic graft‐versus‐host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft‐versus‐host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant2006;12:375. CrossRef

46. Anon. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet1990;335:1078.

47. ChoiIJ, KimJS, ChaSD, et al.Long‐term clinical course and prognostic factors in intestinal Behcet's disease. Dis Colon Rectum2000;43:692. CrossRef

48. OzencA, BayraktarY, BaykalA. Pyloric stenosis with esophageal involvement in Behcet's syndrome. Am J Gastroenterol1990;85:727.

49. ArendtT, KloehnS, BastianA, et al.A case of Behcet's syndrome presenting with Dieulafoy's ulcer. Z Gastroenterol1997;35:935.

50. AlpsoyE. Behcet's disease: treatment of mucocutaneous lesions. Clin Exp Rheumatol2005;23:532.

51. DavatchiF, ShahramF, Chams‐DavatchiC, et al.How to deal with Behcet's disease in daily practice. Int J Rheum Dis2010;13:105. CrossRef

52. YurdakulS, MatC, TuzunY, et al.A double‐blind trial of colchicine in Behcet's syndrome. Arthritis Rheum2001;44:2686. CrossRef

53. YaziciH, PazarliH, BarnesCG, et al.A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med1990;322:281. CrossRef

54. HamuryudanV, OzyazganY, HizliN, et al.Azathioprine in Behcet's syndrome: effects on long‐term prognosis. Arthritis Rheum1997;40:769. CrossRef

55. MelikogluM, FreskoI, MatC, et al.Short‐term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol2005;32:98.

56. AridaA, FragiadakiK, GiavriE, et al.Anti‐TNF agents for Behcet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum2011;41:61. CrossRef

57. HatemiG, SilmanA, BangD, et al.Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence‐based recommendations for the management of Behcet disease. Ann Rheum Dis2009;68:1528. CrossRef

58. HatemiG, SilmanA, BangD, et al.EULAR recommendations for the management of Behcet disease. Ann Rheum Dis2008;67:1656. CrossRef

59. MasudaK, NakajimaA, UrayamaA, et al.Double‐masked trial of cyclosporin versus colchicine and long‐term open study of cyclosporin in Behcet's disease. Lancet1989;1:1093. CrossRef

60. AlpsoyE, DurusoyC, YilmazE, et al.Interferon alfa‐2a in the treatment of Behcet disease: a randomized placebo‐controlled and double‐blind study. Arch Dermatol2002;138:467. CrossRef

61. HamuryudanV, MatC, SaipS, et al.Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double‐blind, placebo‐controlled trial. Ann Intern Med1998;128:443. CrossRef

62. Gardner‐MedwinJM, SmithNJ, PowellRJ. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis1994;53:828. CrossRef

63. BegbieME, WallaceGM, ShovlinCL. Hereditary haemorrhagic telangiectasia (Osler‐Weber‐Rendu syndrome): a view from the 21st century. Postgrad Med J2003;79:18. CrossRef

64. KjeldsenAD, MollerTR, BrusgaardK, et al.Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. J Intern Med2005;258:349. CrossRef

65. FuchizakiU, MiyamoriH, KitagawaS, et al.Hereditary haemorrhagic telangiectasia (Rendu‐Osler‐Weber disease). Lancet2003;362:1490. CrossRef

66. ShovlinCL, GuttmacherAE, BuscariniE, et al.Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu‐Osler‐Weber syndrome). Am J Med Genet2000;91:66. CrossRef

67. YanivE, PreisM, ShevroJ, et al.Anti‐estrogen therapy for hereditary hemorrhagic telangiectasia – a long‐term clinical trial. Rhinology2011;49:214.

68. JamesonJJ, CaveDR. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope2004;114:705. CrossRef

69. Morales‐AnguloC, Perez del MolinoA, ZarrabeitiaR, et al.[Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu‐Osler‐Weber disease) with tranexamic acid]. Acta Otorrinolaringol Esp2007;58:129. CrossRef

70. SuksamanapunN, TrakarnsangaA, AkaraviputhT. Blue rubber bleb nevus syndrome. Endoscopy2011;43(Suppl 2 UCTN):E411. CrossRef

71. AgneseM, CipollettaL, BiancoMA, et al.Blue rubber bleb nevus syndrome. Acta Paediatr2010;99:632. CrossRef

72. YuksekkayaH, OzbekO, KeserM, et al.Blue rubber bleb nevus syndrome: successful treatment with sirolimus. Pediatrics2012;129:e1080. CrossRef

73. GonzalezD, ElizondoBJ, HaslagS, et al.Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber‐bleb nevus syndrome. J Pediatr Gastroenterol Nutr2001;33:183. CrossRef

74. MavrogenisG, CoumarosD, TzilvesD, et al.Cyanoacrylate glue in the management of blue rubber bleb nevus syndrome. Endoscopy2011;43(Suppl 2 UCTN):E291. CrossRef

75. NgEK, CheungFK, ChiuPW. Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator. Dig Endosc2009;21:40. CrossRef

76. EmamiMH, HaghdaniS, TavakkoliH, et al.Endoscopic polypectomy resection of blue rubber bleb nevus lesions in small bowel. Indian J Gastroenterol2008;27:165.

77. NijhawanS, KumarD, JoshiA, et al.Endoscopic band ligation for non variceal bleed. Indian J Gastroenterol2004;23:186.

78. BotteroA, BenedettiL, SassonL, et al.[Diagnosis and treatment of gastrointestinal bleeding in Bean syndrome]. Acta Gastroenterol Latinoam2008;38:278.

79. ChoiKK, KimJY, KimMJ, et al.Radical resection of intestinal blue rubber bleb nevus syndrome. J Korean Surg Soc2012;83:316. CrossRef

80. FishmanSJ, SmithersCJ, FolkmanJ, et al.Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg2005;241:523. CrossRef

81. GardnerEJ. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet1951;3:167.

82. WijnMA, KellerJJ, GiardielloFM, et al.Oral and maxillofacial manifestations of familial adenomatous polyposis. Oral Dis2007;13:360. CrossRef

83. GiardielloFM, HylindLM, TrimbathJD, et al.Oral contraceptives and polyp regression in familial adenomatous polyposis. Gastroenterology2005;128:1077. CrossRef

84. OkuT, TakayamaT, SatoY, et al.A case of Gardner syndrome with a mutation at codon 1556 of APC: a suggested case of genotype‐phenotype correlation in dental abnormality. Eur J Gastroenterol Hepatol2004;16:101. CrossRef

85. BisgaardML, BulowS. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A2006;140:200. CrossRef

86. JeghersH, McKusickVA, KatzKH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med1949;241:1031. CrossRef

87. GiardielloFM, WelshSB, HamiltonSR, et al.Increased risk of cancer in the Peutz‐Jeghers syndrome. N Engl J Med1987;316:1511. CrossRef

88. PilarskiR, EngC. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet2004;41:323. CrossRef

89. GraveB, McCulloughM, WiesenfeldD. Orofacial granulomatosis–a 20‐year review. Oral Dis2009;15:46. CrossRef

90. PatelP, BrostoffJ, CampbellH, et al.Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy2013;3:26. CrossRef

91. WhiteA, NunesC, EscudierM, et al.Improvement in orofacial granulomatosis on a cinnamon‐ and benzoate‐free diet. Inflamm Bowel Dis2006;12:508. CrossRef

92. WrayD, ReesSR, GibsonJ, et al.The role of allergy in oral mucosal diseases. QJM2000;93:507. CrossRef

93. MignognaMD, FedeleS, Lo RussoL, et al.Orofacial granulomatosis with gingival onset. J Clin Periodontol2001;28:692. CrossRef

94. CampbellHE, EscudierMP, PatelP, et al.Review article: cinnamon‐ and benzoate‐free diet as a primary treatment for orofacial granulomatosis. Aliment Pharmacol Ther2011;34:687. CrossRef

95. van der WaalRI, SchultenEA, van der MeijEH, et al.Cheilitis granulomatosa: overview of 13 patients with long‐term follow‐up–results of management. Int J Dermatol2002;41:225. CrossRef

96. SussmanGL, YangWH, SteinbergS. Melkersson‐Rosenthal syndrome: clinical, pathologic, and therapeutic considerations. Ann Allergy1992;69:187.

97. ElliottT, CampbellH, EscudierM, et al.Experience with anti‐TNF‐alpha therapy for orofacial granulomatosis. J Oral Pathol Med2011;40:14. CrossRef

98. EpsteinJB, ThariatJ, BensadounRJ, et al.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin2012;62:400. CrossRef

99. SonisST, EltingLS, KeefeD, et al.Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer2004;100(9 Suppl):1995. CrossRef

100. WattersAL, EpsteinJB, AgulnikM. Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol2011;47:441. CrossRef

101. SonisS, TreisterN, ChawlaS, et al.Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer2010;116:210.

102. RanjitkarS, SmalesRJ, KaidonisJA. Oral manifestations of gastroesophageal reflux disease. J Gastroenterol Hepatol2012;27:21. CrossRef

103. OchiaiD, MiyakoshiK, YakuboK, et al.Familial blue rubber bleb nevus syndrome in pregnancy with spinal epidural involvement. Case Rep Obstet Gynecol2013;2013:141506.

104. PanjwaniS, BagewadiA, KeluskarV, et al.Gardner's syndrome. J Clin Imaging Sci2011;1:65. CrossRef

105. MeletiM, VescoviP, MooiWJ, et al.Pigmented lesions of the oral mucosa and perioral tissues: a flow‐chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2008;105:606. CrossRef

106. FredH, van DijkH. Images of memorable cases: cases 115 and 116. Connexions, 2008. Available at: http://cnx.org/content/m15016/1.3/ (accessed 5 October 2013).